Latest Posts

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Enabling next-generation medicines and cures. We transform healthcare with AI and data

Our Augmented Intelligence-powered Life Sciences Platform provides solutions to discover and develop safer and more successful medicines for patients

Learn More

WHAT WE OFFER

Drug Discovery and Development

We harness proprietary Artificial Intelligence and Machine Learning to provide unprecedented causal insights from the global data universe comprising Life Sciences, human data and real world data. These causal insights capture the biological complexity of diseases and deliver therapeutic strategies to enable treatment of incurable diseases and transform development of effective medicines.
Our proprietary capabilities in Life Science Language Processing™ and Computer Vision contextualize multimodal data, discover non-obvious connections, and accelerate development of drugs and therapies from early stage drug discovery to commercialization irrespective of therapeutic area and modality.
pharmaceutical-women

Our Offerings

Enabling all stages of a drug’s life cycle.

Ontosight® Platform

For large pharma, biotechs and CROs
In an era of global transformation, where scientific knowledge, human data and AI/ML shape the future of drug discovery and healthcare, our Ontosight® solutions support all stages of drug development from ideation to market. Ontosight® modules offer an unbiased, holistic and integrated approach to discover and develop medicines and therapies independent of therapeutic area, indication and modality.
Network of biological entities
Differentially expressed candidate bio-markers
Network of biological entities
1.1 Network of biological entities
1.2 Differentially expressed candidate bio-markers
Differentially expressed candidate bio-markers
1.1 Network of biological entities
1.2 Differentially expressed candidate bio-markers

Search & Explore

For large pharma, biotechs and CROs

Scientific knowledge aggregation and mining platform that facilitates searching, screening and synthesizing information from all relevant, globally available sources of biomedical knowledge covering all life sciences disciplines. Visualize ‘never-thought-to-be-linked’ biological entities and pathophysiological concepts that underlie complex diseases to identify the Achilles’ heel of disease and build a tailored therapeutic strategy. Track over 23+ million researchers, investigators, and key opinion leaders (KOLs) globally.

Dashboards

For medical affairs, regulatory affairs, BD&L teams and clinical design teams.

Clean, structure, consolidate and combine diversified and disparate datasets from various public, enterprise, third-party and other siloed sources to enable integrative data analysis. Automated analytics of developing and scaling data environments with tailored and intuitive visualization that enables decision-making.

Amrit Ecosystem

Enabling Decentralized Science for equitable and efficient healthcare by leveraging AI and Blockchain technologies.

Hospitals and Patients

Receive *tokens for providing data, can donate tokens, can buy in-app services with tokens, e.g. second opinion, digital therapeutics

Pharma & Academic Institutes

Run surveys using tokens, pay tokens for participation, license data in and out

Investors

Can buy tokens on the secondary exchange and profit from the value increase

Regulators & PAGs

Receive donations, facilitate discovery and other programs for patients
* Tokens are not applicable to U.S. citizens.
Hospital Dashboard
CT Recruitment
Patient App

HOW WE WORK

Deep Collaboration with Pharma and Biotech partners to resolve bottlnecks in iterative milestones
Patented AI Technology, Aggregates and Analyzes data
Robust Medical Validation and enterprise level security by Subject matter experts.
Our comprehensive patent portfolio

Our Technology

48.9M+

Publications

830K+

Clinical trials

2.2M+

Congresses

4.6M+

Grants

1.5M+

Thesis & dissertations

200K+

Protein, gene & drugs

9.4M+

Patents

Public
Data

extracts

structured information from unstructured webpages, PDFs, images, biological databases etc.

crawls

up to 10 billion web pages per day in real-time

scans

95 % of the world wide web and identifies relevant pages such as literature, experimental data etc.
VIRTUAL LIFE SCIENCE PLATFORM

enables

to incentivize data exchange, integrating proprietary data

broadcasts

Smart contracts and IP claims on an immutable ledger

allows

federated learning over distributed data with absolute privacy

Proprietary
Data

326M+

web domains

50K+

sources updated daily

1M+

Clinical trials & Preclinical studies

40M+

Biomedical terms & concepts

1.5M+

patients records